Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc.
University of Pennsylvania
Sanofi
Gilead Sciences
Roswell Park Cancer Institute
University of Pennsylvania
Caribou Biosciences, Inc.
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Hoffmann-La Roche
Institute of Hematology & Blood Diseases Hospital, China
University of Colorado, Denver
Loyola University
Washington University School of Medicine
Fate Therapeutics
Bellicum Pharmaceuticals
University of Nebraska
Medical College of Wisconsin
Fred Hutchinson Cancer Center
Kiadis Pharma
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Celularity Incorporated
Medical College of Wisconsin
Therapeutic Advances in Childhood Leukemia Consortium
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Washington University School of Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Pennsylvania
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Hospital Israelita Albert Einstein
St. Jude Children's Research Hospital
University of Rochester
New York Medical College
King's College Hospital NHS Trust
Indiana University
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute